Skip navigation

DSpace JSPUI

DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets

Learn More
DSpace logo
English
中文
  • Browse
    • Communities
      & Collections
    • Publication Year
    • Author
    • Title
    • Subject
  • Search TDR
  • Rights Q&A
    • My Page
    • Receive email
      updates
    • Edit Profile
  1. NTU Theses and Dissertations Repository
  2. 生物資源暨農學院
  3. 獸醫專業學院
  4. 臨床動物醫學研究所
Please use this identifier to cite or link to this item: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/6816
Full metadata record
???org.dspace.app.webui.jsptag.ItemTag.dcfield???ValueLanguage
dc.contributor.advisor蘇璧伶
dc.contributor.authorFeng-Hsuan Chuen
dc.contributor.author朱鳳軒zh_TW
dc.date.accessioned2021-05-17T09:18:44Z-
dc.date.available2017-10-12
dc.date.available2021-05-17T09:18:44Z-
dc.date.copyright2012-10-12
dc.date.issued2012
dc.date.submitted2012-09-26
dc.identifier.citation黃宣憲。2005。犬瘟熱感染犬隻臨床檢體隻病毒核酸偵測、定量及H基因之序列分析。國立台灣大學獸醫研究所碩士論文。
Alldinger S, Baumgärtner W, Örvell C .,1993, Restricted expression of viral surface proteins in canine distemper encephalitis. Acta Neuropathol 85:635–645
Alldinger, S., Baumgartner, W., van Moll, P., Orvell, C., 1993, In vivo and in vitro expression of canine distemper viral proteins in dogs and non-domestic
carnivores. Arch Virol 132, 421-428.
Alldinger S, Wunschmann A, Baumgärtner W, Voss C,Kremmer E., 1996, Up-regulation of major histocompatibility complex class II antigen expression in the central nervous system of dogs with spontaneous canine distemper virus encephalitis. Acta Neuropathol 92:273–280
Appel MJ.,1969, Pathogenesis of canine distemper. Am J Vet Res 30:1167–1182.
Appel, M.J., 1970, Distemper pathogenesis in dogs. J. Am. Vet. Med. Assoc. 156, 1681–1684.
Appel, M.J.G., Gillespie, J.H., 1972. Canine distemper virus. In: Gard, S.,Hallauer, C., Meyer, K.F. (Eds.), Virology Monographs, vol. 11.Springer, New York, pp. 1–96.
Appel, M.J.G., Stuart G., Mendelson, Hall W.W., 1984. Macrophage Fc receptors control infectivity and neutralization of canine distemper virus-antibody complexes. Journal of Virology, vol. 51 no. 3, 643-649.
Appel, M.J., Shek, W.R., Shesberadaran, H., Norrby, E., 1984, Measles virus and inactivated canine distemper virus induce incomplete immunity to canine distemper. Arch Virol 82, 73-82.
Appel, M.J., Shek, W.R., Summers, B.A., 1982, Lymphocyte-mediated immune cytotoxicity in dogs infected with virulent canine distemper virus. InfectImmun 37, 592-600.
Appel, M.J., Yates, R.A., Foley, G.L., Bernstein, J.J., Santinelli, S., Spelman, L.H.,
Miller, L.D., Arp, L.H., Anderson, M., Barr, M., et al., 1994, Canine distemper epizootic in lions, tigers, and leopards in North America. 6, 277-288.
Baumgartner, W., Orvell, C., Reinacher, M., 1989, Naturally occurring canine distemper virus encephalitis: distribution and expression of viral polypeptides in nervous tissues. Acta Neuropathol 78, 504-512.
Beineke, A., Puff, C., Seehusen, F., Baumgartner, W., 2009, Pathogenesis and immunopathology of systemic and nervous canine distemper. Vet ImmunolImmunopathol 127, 1-18.
Blixenkrone-Møller, M., 1989. Detection of intracellular canine distemper virus antigen in mink inoculated with an attenuated or a virulent strain of canine distemper virus. Am. J. Vet. Res. 50, 1616–1620.
Blixenkrone-Møller, M., Svansson, V., Have, P., Botner, A., Nielsen, J., 1989.Infection studies in mink with seal-derived morbillivirus. Arch. Virol.106, 165–170.
Bolt, G., Jensen, T.D., Gottschalck, E., Arctander, P., Appel, M.J., Buckland, R.,Blixenkrone-Moller, M., 1997, Genetic diversity of the attachment (H) protein
gene of current field isolates of canine distemper virus. J Gen Virol 78 ( Pt 2),367-372.
Bollo E, Zurbriggen A, Vandevelde M, Fankhauser R ,1986. Canine distemper virus clearance in chronic inflammatory demyelination. Acta Neuropathol 72:69–73
Botteron C, Zurbriggen A, Griot C, Vandevelde M,1992. Canine distemper virus-immune complexes induce bystander degeneration of oligodendrocytes. Acta Neuropathol 83:402–407
Bürge T, Griot C, Vandevelde M, Peterhans E (1989) Antiviral antibodies stimulate production of reactive oxygen species in cultured canine brain cells infected with canine distemper virus. J Virol 63:2790–2797
Chappuis, G., 1995, Control of canine distemper. Vet Microbiol 44, 351-358
Chen, C.C., Pei, K.J., Liao, M.H., Mortenson, J.A., 2008, Canine distemper virus in  wild ferret-badgers of Taiwan. J Wildl Dis 44, 440-445
Frisk, A.L., Konig, M., Moritz, A., Baumgartner, W., 1999, Detection of canine distemper virus nucleoprotein RNA by reverse transcription-PCR using serum, whole blood, and cerebrospinal fluid from dogs with distemper. J Clin Microbiol 37, 3634-3643.
Gemma, T., Miyashita, N., Shin, Y.S., Okita, M., Mori, T., Iwatsuki, K., Mikami, T.,Kai, C., 1995, Serological survey of canine distemper virus infection using enzyme-linked
immunosorbent assay. J Vet Med Sci 57, 761-763
Gerber, J.D., Marron, A.E., 1976, Cell-mediated immunity and age at vaccination associated with measles inoculation and protection of dogs against canine distemper. Am J Vet Res 37, 133-138.
Giraudon, P., Wild, T.F., 1985, Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal
antibodies is related to their hemagglutination inhibiting activity. Virology 144, 46-58.
Glaus, T., Griot, C., Richard, A., Althaus, U., Herschkowitz, N., Vandevelde, M.,1990, Ultrastructural and biochemical findings in brain cell cultures infected
with canine distemper virus. Acta Neuropathol 80, 59-67.
Graber H, Mu¨ ller C, Vandevelde M, Zurbriggen A., 1995. Restricted infection with canine distemper virus leads to downregulation of myelin gene transcription in cultured oligodendrocytes. Acta Neuropathol 90:312–318
Greene, C.E., Appel, M.J., 1998, Infectious Diseases of the Dogs and Cats II 9-22.
Greene, C.E., Appel, M.J., 2012, Infectious Diseases of the Dogs and Cats II 25-42.
Griot, C., Burge, T., Vandevelde, M., Peterhans, E., 1989, Antibody-induced generation of reactive oxygen radicals by brain macrophages in canine distemper encephalitis: a mechanism for bystander demyelination. Acta
Neuropathol 78, 396-403
Griot-Wenk M, Griot C, Pfister H, Vandevelde M ,1991. Antibody-dependent cellular cytotoxicity in antimyelin antibody induced oligodendrocyte damage in vitro. J Neuroimmunol.33:145–155
Grone, A., Engelhardt, P., Zurbriggen, A., 2003, Canine distemper virus infection:proliferation of canine footpad keratinocytes. Vet Pathol 40, 574-578.
Gröne A, Fonfara S, Baumgartner W (2002) Cell type-dependent cytokine expression after canine distemper virus
infection.Viral Immunol 15:493–505
Guillaume, V., Contamin, H., Loth, P., Georges-Courbot, M.C., Lefeuvre, A.,Marianneau, P., Chua, K.B., Lam, S.K., Buckland, R., Deubel, V., Wild, T.F.,2004, Nipah virus: vaccination and passive protection studies in a hamster
model. J Virol 78, 834-840.
Haines, D.M., Martin, K.M., Chelack, B.J., Sargent, R.A., Outerbridge, C.A., Clark,E.G., 1999, Immunohistochemical detection of canine distemper virus in
haired skin, nasal mucosa, and footpad epithelium: a method for antemortem diagnosis of infection. J Vet Diagn Invest 11, 396-399.
Hartley, M.J., 1974, A post-vaccinal inclusion body encephalitis in dogs. Vet Pathol 11, 301-312.
Hashimoto, M., Une, Y., Mochizuki, M., 2001, Hemagglutinin genotype profiles of canine distemper virus from domestic dogs in Japan. Arch Virol 146, 149-155.
Hathaway, L.J., Obeid, O.E., Steward, M.W., 1998, Protection against measles virusinduced encephalitis by antibodies from mice immunized intranasally with a synthetic peptide immunogen. Vaccine 16, 135-141
Hirama, K., Goto, Y., Uema, M., Endo, Y., Miura, R., Kai, C., 2004, Phylogenetic analysis of the hemagglutinin (H) gene of canine distemper viruses isolated from wild masked palm civets (Paguma larvata). J Vet Med Sci 66, 1575-
1578.
Hirama, K., Togashi, K., Wakasa, C., Yoneda, M., Nishi, T., Endo, Y., Miura, R.,Tsukiyama-Kohara, K., Kai, C., 2002, Cytotoxic T-lymphocyte activity specific for hemagglutinin (H) protein of canine distemper virus in dogs. J Vet
Med Sci 65, 109-112.
Hirayama, N., Senda, M., Nakashima, N., Takagi, M., Sugiyama, M., Yoshikawa, Y.,Yamanouchi, K., 1991, Protective effects of monoclonal antibodies against
lethal canine distemper virus infection in mice. J Gen Virol 72 , 2827-2830.
Ho, C.K., Babiuk, L.A., 1980, Immune mechanisms against canine distemper. III.Role of complement lysis in the immunity and persistent infection of canine
distemper virus. Immunology 39, 231-237
Ho, C.K., Babiuk, L.A., 1979, Immune mechanisms against canine distemper. II.Role of antibody in antigen modulation and prevention of intercellular and extracellular spread of canine distemper virus. Immunology 38, 765-772.
Ikeda, Y., Nakamura, K., Miyazawa, T., Chen, M.C., Kuo, T.F., Lin, J.A., Mikami, T.,Kai, C., Takahashi, E., 2001, Seroprevalence of canine distemper virus in cats.Clin Diagn Lab Immunol 8, 641-644
Jozwik, A., Frymus, T., 2002, Natural distemper in vaccinated and unvaccinated dogs in Warsaw. J Vet Med B Infect Dis Vet Public Health 49, 413-414.
Kim, Y.H., Cho, K.W., Youn, H.Y., Yoo, H.S., Han, H.R., 2001a, Detection of canine distemper virus (CDV) through one step RT-PCR combined with nested PCR.2, 59-63.
Kim, Y.H., Cho, K.W., Youn, H.Y., Yoo, H.S., Han, H.R., 2001b, Detection of canine distemper virus (CDV) through one step RT-PCR combined with nested PCR.
J Vet Sci 2, 59-63.
Koestner, A., 1975, Animal model of human disease: subacute sclerosing panencephalitis, multiple sclerosis; animal model: distemper-associated demyelinating encephalomyelitis. Am J Pathol 78, 361-364
Krakowka, S., Higgins, R.J., Metzler, A.E., 1980, Plasma phase viremia in canine distemper virus infection. Am J Vet Res 41, 144-146.
Kubo T., Kagawa Y, Taniyama H., Hasegawa A., 2007, Distribution of inclusion bodies in tissues from 100 dogs infected with canine distemper virus. J. Vet. Med. Sci. 69(5): 527–529.
Krakowka, S., Olsen R.G., Axthelm, M.K., Rice, J., Winters, K., 1982, Canine parvovirus infection potentiates canine distemper encephalitis attributable to modified live-virus vaccine. J Am Vet Med Assoc 180, 137-139.
Krakowka, S., Long, D., Koestner, A., 1978, Influence of transplacentally acquired antibody on neonatal susceptibility to canine distemper virus in gnotobiotic dogs. J Infect Dis 137, 605-608.
Krakowka, S., Olsen, R., Confer, A., Koestner, A., McCullough, B., 1975, Serologic response to canine distemper viral antigens in gnotobiotic dogs infected with canine distemper virus. J Infect Dis 132, 384-392.
Krakowka, S., Wallace, A.L., 1979. Lymphocyte-associated immune responses to canine distemper and measles viruses in distemper infected gnotobiotic dogs. Am. J. Vet. Res. 40, 669–672.
Lan, N.T., Yamaguchi, R., Kawabata, A., Uchida, K., Kai, K., Sugano, S., Tateyama,S., 2006b, Stability of canine distemper virus (CDV) after 20 passages in Vero-DST cells expressing the receptor protein for CDV. Vet Microbiol 118,177-188.
Lauder, I.M., Martin, W.B., Gordon, E.B., Lawson, D.D., Campbell, R.S.F.,Watrach, A.M., 1954. Vet. Rec. 66, 607–611
Lednicky, J.A., Dubach, J., Kinsel, M.J., Meehan, T.P., Bocchetta, M. Hungerford, L.L., Sarich, N.A., Witecki, K.E., Braid, M.D., Pedrak, C., Houde, C.M.,2004a, Genetically distant American Canine distemper virus lineages have recently caused epizootics with somewhat different characteristics in raccoons living around a large suburban zoo in the USA. Virol J 1, 2
Lednicky, J.A., Meehan, T.P., Kinsel, M.J., Dubach, J., Hungerford, L.L., Sarich,N.A., Witecki, K.E., Braid, M.D., Pedrak, C., Houde, C.M., 2004b, Effectiveprimary isolation of wild-type canine distemper virus in MDCK, MV1 Lu and Vero cells without nucleotide sequence changes within the entire haemagglutinin protein gene and in subgenomic sections of the fusion and phospho protein genes. J Virol Methods 118, 147-157.
Liang, C.T., Chueh, L.L., Lee, K.H., Huang, H.S., Uema, M., Watanabe, A., Miura, R., Kai, C., Liang, S.C., Yu, C.K., Liu, C.H., 2008, Phylogenetic Analysis and Isolation of Canine Distemper Viruse in Taiwan. Taiwan Vet J 34, 198-210
Liang, C.T., Chueh, L.L., Pang, V.F., Zhuo, Y.X., Liang, S.C., Yu, C.K., Chiang, H.,Lee, C.C., Liu, C.H., 2007, A non-biotin polymerized horseradish-peroxidase method for the immunohistochemical diagnosis of canine distemper. J Comp Pathol 136, 57-64.
Markus S, Failing K, Baumgartner W.,2002. Increased expression of pro-inflammatory cytokines and lack of up-regulation of anti-inflammatory cytokines in early distemper CNS lesions. J Neuroimmunol 125:30–4
Martella, V., Elia, G., Buonavoglia, C., 2008, Canine
distemper virus. Vet Clin North Am Small Anim Pract 38, 787-797, vii-viii.
Martella, V., Pratelli, A., Cirone, F., Zizzo, N., Decaro, N., Tinelli, A., Foti, M.,Buonavoglia, C., 2002, Detection and genetic characterization of canine distemper virus (CDV) from free-ranging red foxes in Italy. Mol Cell Probes
16, 77-83
Max, J.G., Appel, M.J., 1978, Reversion to virulence of attenuated canine distemper virus in vivo and in vitro. J Gen Virol 41, 385-393.McCullough, B., Krakowka, S., Koestner, A., 1974b, Experimental canine distemper virus-induced demyelination. Lab Invest 31, 216-222.
McCullough, B., Krakowka, S., Koestner, A., Shadduck, J., 1974a, Demyelinating activity of canine distemper virus isolates in gnotobiotic dogs. J Infect Dis
130, 343-350
Miele, J.A., Krakowka, S., 1983, Antibody responses to virion polypeptides in gnotobiotic dogs infected with canine distemper virus. Infect Immun 41, 869-871.
Mochizuki, M., Hashimoto, M., Hagiwara, S., Yoshida, Y., Ishiguro, S., 1999,Genotypes of canine distemper virus determined by analysis of the hemagglutinin genes of recent isolates from dogs in Japan. J Clin Microbiol
37, 2936-2942.
Moro, L., de Sousa Martins, A., de Moraes Alves, C., de Araujo Santos, F.G., dos Santos Nunes, J.E., Carneiro, R.A., Carvalho, R., Vasconcelos, A.C., 2003,
Apoptosis in canine distemper. Arch Virol 148, 153-164.
Murphy, F.A., 1999, Veterinary Virology, In: Gibbs, E.P.J., Horzinek, M.C., Studdert, M.J. (Ed.), pp. 411-428.
Okita, M., Yanai, T., Ochikubo, F., Gemma, T., Mori, T., Maseki, T., Yamanouchi, K.,Mikami, T., Kai, C., 1997, Histopathological features of canine distemper recently observed in Japan. J Comp Pathol 116, 403-408.
Ono, N., Tatsuo, H., Tanaka, K., Minagawa, H., Yanagi, Y., 2001, V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor. J Virol 75, 1594-1600.
Orlando, E.A., Imbschweiler, I., Gerhauser, I.,Baumgartner, W., Wewetzer, K., 2008,In vitro characterization and preferential infection by canine distemper virus of glial precursors with Schwann cell characteristics from adult canine brain. Neuropathol Appl Neurobiol 34, 621-637
Parker, A.J., 1978. The many faces of canine distemper. Canine Pract. 14, 25–28.
Penny A., Acute canine distemper encephalitis is associated with rapid neuronal loss and local immune activation. Journal of General Virology. 91, 980–989, 2010
Raw, M.E., Pearson, G.R., Brown, P.J., Baumgartner, W., 1992, Canine distemper infection associated with acute nervous signs in dogs. Vet Rec 130, 291-293
Rima, B.K., Baczko, K., Clarke, D.K., Curran, M.D., Martin, S.J., Billeter, M.A., ter Meulen, V., 1986,Characterization of clones for the sixth (L) gene and a transcriptional map for morbilliviruses. J Gen Virol 67 ( Pt 9), 1971-1978.
Rima, B.K., Duffy, N., Mitchell, W.J., Summers, B.A., Appel, M.J., 1991, Correlation between humoral immune responses and presence of virus in the CNS in dogs experimentally infected with canine distemper virus. Arch Virol 121, 1-8
Rockborn, G., 1958. Further studies on viremia and neutralizing antibodiesin naturally acquired distemper in dogs. Arch. Gesamte Virusforsch.
8, 500–510.
Rudd, P.A., Cattaneo, R., von Messling, V., 2006, Canine distemper virus uses both the anterograde and the hematogenous pathway for neuroinvasion. J Virol 80, 9361-9370
Rzezutka, A., Mizak, B., 2002, Application of N-PCR for diagnosis of distemper in dogs and fur animals. Vet Microbiol 88, 95-103.
Schobesberger M, Zurbriggen A, Doherr MG, Weissenbock H,Vandevelde M, Lassmann H, Griot C., 2002. Demyelination precedes oligodendrocyte loss in canine distemper virus-induced encephalitis. Acta Neuropathol 103:11–19
Schobesberger, M., Summerfield, A., Doherr, M.G., Zurbriggen, A., Griot, C., 2005, Canine distemper virus-induced depletion of uninfected lymphocytes is associated with apoptosis. Vet Immunol Immunopathol 104, 33-44.
Seibel, H., Baumgartner, W., Muller, G., Wohlsein, P., Siebert, U., 2007,[Retrospective analysis of two phocine distemper epidemics in the North and Baltic Seas in 1988 and 2002]. Dtsch Tierarztl Wochenschr 114, 284-293.
Seki F, Ono N, Yamaguchi R, Yanagi Y (2003) Efficient isolation of wild strains of canine distemper virus in Vero cells expressing canine SLAM (CD150) and their adaptability to marmoset B95a cells. J Virol 77:9943–9950
Shek, W.R., Schultz, R.D., Appel, M.J., 1980. Natural and immune cytolysis of canine distemper virus-infected target cells. Infect. Immun. 28, 724–734
Shin, Y.J., Cho, K.O., Cho, H.S., Kang, S.K., Kim, H.J., Kim, Y.H., Park, H.S., Park,N.Y., 2004, Comparison of one-step RT-PCR and a nested PCR for the detection of canine distemper virus in clinical samples. Aust Vet J 82, 83-86.
Si, W., Zhou, S., Wang, Z., Cui, S.J., 2010, A multiplex reverse transcription-nested polymerase chain reaction for detection and differentiation of wild-type and vaccine strains of canine distemper virus. Virol J 7, 86.
Sidhu, M.S., Husar, W., Cook, S.D., Dowling, P.C., Udem, S.A., 1993, Canine distemper terminal and intergenic non-protein coding nucleotide sequences:
completion of the entire CDV genome sequence. Virology 193, 66-72.
Soma, T., Ishii, H., Hara, M., Ohe, K., Hagimori, I., Ishikawa, Y., Taneno, A., 2003,Detection of canine distemper virus antigen in canine serum and its application to diagnosis. Vet Rec 153, 499-501
Summers, B.A., Greisen, H.A., Appel, M.J., 1979, Early events in canine distemper demyelinating encephalomyelitis. Acta Neuropathol 46, 1-10.
Summers, B.A., Whitaker, J.N., Appel, M.J., 1987, Demyelinating canine distemper encephalomyelitis: measurement of myelin basic protein in cerebrospinal fluid. J Neuroimmunol 14, 227-233.
Tipold A, Moore P, Zurbriggen A, Burgener I, Barben G, Vandevelde M.,1999. Early T-cell response in the central nervous system in canine distemper virus infection. Acta Neuropathol 97:45–56
Tipold A, Vandevelde M, Wittek R, Moore P, Summerfield A, Zurbriggen A., 2001. Partial protection and intrathecal invasion of CD8(+) T cells in acute canine distemper virus infection.Vet Microbiol 83:189–203
Vandevelde M, Fankhauser R, Kristensen F, Kristensen B., 1981. Immunoglobulins in demyelinating lesions in canine distemper encephalitis. An immunohistological study. Acta Neuropathol 54:31–41
Vandevelde, M., Higgins, R.J., Kristensen, B., Kristensen, F., Steck, A.J., Kihm,U.,1982, Demyelination in experimental canine distemper virus infection:
immunological, pathologic, and immunohistological studies. Acta Neuropathol 56, 285-293.
Vandevelde, M., Zurbriggen, A., 2005, Demyelination in canine distemper virus infection: a review. Acta Neuropathol 109, 56-68.
Vandevelde, M., Zurbriggen, A., Higgins, R.J., Palmer, D., 1985 b, Spread and distribution of viral antigen in nervous canine distemper. Acta Neuropathol 67, 211-218
Vandevelde M, Zurbriggen A, Steck A, Bichsel P., 1986. Studies on the intrathecal humoral immune response in canine distemper encephalitis. J Neuroimmunol 11:41–51
von Messling, V., Harder, T.C., Moennig, V., Rautenberg, P., Nolte, I., Haas, L., 1999, Rapid and sensitive detection of immunoglobulin M (IgM) and IgG antibodies against canine distemper virus by a new recombinant nucleocapsid proteinbased enzyme-linked immunosorbent assay. J Clin Microbiol 37, 1049-1056.
von Messling, V., Springfeld, C., Devaux, P., Cattaneo, R., 2003, A ferret model of canine distemper virus virulence and immunosuppression. J Virol 77, 12579-
12591.
von Messling, V., Zimmer, G., Herrler, G., Haas, L., Cattaneo, R., 2001, The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity. J Virol 75, 6418-6427.
Wakasa, C., Iwatsuki, K., Ohashi, K., Nakamura, K., Kai, C., 2000, Sequence analysis of the genes encoding the phosphoprotein of recent isolates of canine distemper virus in Japan. J Vet Med Sci 62, 97-101.
Wohlsein, P., Muller, G., Haas, L., Siebert, U., Harder, T.C., Baumgartner, W., 2007, Antigenic characterization of phocine distemper virus causing mass mortality in 2002 and its relationship to other morbilliviruses. Arch Virol 152, 1559-1564.
Wright, N.G., Cornwell, H.J., Thompson, H., Lauder, I.M., 1974, Canine distemper: current concepts in laboratory and clinical diagnosis. Vet Rec 94, 86-92.
Wunschmann A, Alldinger S, Kremmer E, Baumga¨ rtner W., 1999.Identification of CD4+ and CD8+ T cell subsets and B cells in the brain of dogs with spontaneous acute, subacute-, and chronic-demyelinating distemper encephalitis. Vet Immunol Immunopathol 67:101–116
Wunschmann A., Kremmer E., Baumgartner W., 2000. Phenotypical characterization of T and B cell areas in lymphoid tissues of dogs with spontaneous distemper. Vet Immunol Immunopathol 73:83–89
Wyss-Fluehmann, G., Zurbriggen, A., Vandevelde, M., Plattet, P., 2010, Canine distemper virus persistence in demyelinating encephalitis by swift intracellular cell-to-cell spread in astrocytes is controlled by the viral attachment protein. Acta Neuropathol 119, 617-630.
Yoshikawa, Y., Ochikubo, F., Matsubara, Y., Tsuruoka, H., Ishii, M., Shirota, K.,Nomura, Y., Sugiyama, M., Yamanouchi, K., 1989, Natural infection with
canine distemper virus in a Japanese monkey (Macaca fuscata). Vet Microbiol 20, 193-205.
Young, D.F., Randall, R.E., Hoyle, J.A., Souberbielle, B.E., 1990, Clearance of a persistent paramyxovirus infection is mediated by cellular immune responses but not by serum-neutralizing antibody. J Virol 64, 5403-5411.
Zhao, J.J., Yan, X.J., Chai, X.L., Martella, V., Luo, G.L., Zhang, H.L., Gao, H., Liu,Y.X., Bai, X., Zhang, L., Chen, T., Xu, L., Zhao, C.F., Wang, F.X., Shao, X.Q.,Wu, W., Cheng, S.P., 2010, Phylogenetic analysis of the haemagglutinin gene of canine distemper virus strains detected from breeding foxes, raccoon dogs and minks in China. Vet Microbiol 140, 34-42.
Zurbriggen A, Yamawaki M, Vandevelde M (1993) Restricted canine distemper virus infection of oligodendrocytes. Lab Invest 68:277–284
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/6816-
dc.description.abstract犬瘟熱(Canine distemper, CD)為一具高傳染力與高致死率的疾病,臨床上造成全身系統性感染,伴隨著免疫抑制,動物發病早期中和抗體力價之高低會影響疾病的結果,若中和抗體力價持續較低,病毒將無法被清除,進而感染中樞神經系統造成漸進性且多變的神經症狀,出現神經症狀的患犬通常會死亡,僅有少數能耐過。臨床上之治療主要為對症支持治療,但死亡率仍然很高。被動免疫被認為能有效的控制疾病的惡化,然而目前並無實際應用於犬瘟熱患犬療效的報告。本研究目的為評估高免血漿應用於自然感染犬瘟熱患犬的臨床療效。
本研究收集自2009年5月至2011年7月間,至台大動物醫院就診,以RT-nPCR方式確診為犬瘟熱感染之40隻患犬,根據治療方式之不同分為兩組(Group),進一步分析其治療組合的效果。Group 1(n=21)為接受高免血漿與對症支持治療組,Group 2 (n=19)則為僅接受對症支持治療組。總存活率在Group 1為63.6%,Group 2則為36.8%。比較兩組中出現神經症狀患犬,group 1與group 2的存活率分別為50及7.7 %,且有統計上的差異(p<0.05)。此外,Group 1神經症狀發生率為36.4%,低於Group 2的53.8%。Group 1與Group 2於治療期間才出現神經症狀患犬存活率分別為75%和14.3%,兩組間存活率雖無顯著差異(p=0.088),但呈現上升之趨勢。Group 1中死亡的七隻患犬有六隻於就診時已經出現神經症狀,此六隻患犬進行屍體解剖,免疫化學染色顯示各器官與腦中皆有不等程度之病毒分布,其中五隻患犬(83.3%)腦部病理結果歸類於犬瘟熱中樞神經病程之急性期。曾有報告認為過度的抗病毒體液免疫反應可能引發衛星脫髓鞘效應,此現象於這些解剖的患犬病並未被發現。Group1中出現神經症狀時,其存活組與死亡组的血液檢體陽性率分別為57%及0%,兩組間血液檢體的陽性率有統計上的差異(p<0.05)。此外,發生神經症狀同時仍有病毒血症的患犬其死亡率為100%。
本研究證實合併給予高免血漿之治療方式,能提升臨床上犬瘟熱患犬的存活率,特別是出現神經症狀的患犬。給予高免血漿能幫助病毒的清除,降低神經症狀的發生率,因此確診為犬瘟熱感染後,及早合併給予高免血漿為一極佳的治療策略。
zh_TW
dc.description.abstractCanine distemper virus (CDV) is a highly contagious pathogen of dogs causing high mortality. CDV infection can result in a systemic infection with severe immunosuppression. The magnitude of neutralization antibody titers correlates with the outcome of the disease. The constant lack of effective neutralization antibodies causes viral persistence in early stage, and the virus will invade central nervous system (CNS) causing diversely and progressively neurological signs. Dogs with neurological signs usually die, only a few can survive. Supportive or symptomatic therapy is most recommended, however, the mortality of neurological distemper remain very high. Passive immunity was thought to be efficacious in control of disease; nevertheless, the efficacy was never demonstrated in vivo. The aim of this study was to evaluate the clinical efficacy of canine hyperimmune plasma in dogs with canine distemper.
Forty dogs confirmed with CDV infection by RT-nPCR, presented at the National Taiwan University Animal Teaching Hospital between May 2009 and July 2011, were enrolled in this study and divided into two groups for further analysis of different therapeutic combinations. Group 1 (21 dogs) was treated with combination of hyperimmune plasma and supportive therapy. 19 dogs were included in group 2 and were only treated with supportive therapy. The total survival rates were 63.6% and 36.8% in group 1 and group 2, respectively. The survival rates of dogs with neurological signs were 50% and 7.7% in group 1 and group 2, respectively. The survival rate of dogs with neurological signs was significantly higher in group1 than in group2 (p<0.05). Furthermore, the incidence of neurological signs in group 1 was 36.4% and lower than in group 2 (53.8%). The survival rate of dogs appeared neurological signs during therapy was 75% and 14.3% in group 1and group 2, respectively. No significant difference was found between the groups in survival rate (p=0.088), however, it existed an increasing trend. Six of the 7 non-survival dogs in group 1had presented neurological signs at presentation. The immunohistochemistry (IHC) examinations of the six autopsic dogs revealed different degrees of viral distributions in various organs and even in brain. According to pathological results of brain, five of them (83.3%) categorized to be acute stage of neurological distemper. A reported side effect, eg. excessive antiviral humoral immune response might trigger the bystander demyelination, was not observed in this study. In group 1, the positive detection rates of whole blood sample by RT-nPCR upon appearance of neurological signs were 57% in the non-survival group and none in the survival group. There was a significant difference between the two subgroups. In addition, the mortality of dogs presented neurological signs together with viremia was 100%.
In this study, treatment combined with canine hyperimmune plasma was demonstrated to increase survival rate of CDV-infection, especially the dogs have presented with neurological signs. Administration of hyperimmune plasma benefited to eliminate the virus and to decrease the incidence of neurological signs. Therefore, administration of hyperimmune plasma as soon as possible after confirmed diagnosis represents a good therapeutic strategy in the treatment of CD dogs.
en
dc.description.provenanceMade available in DSpace on 2021-05-17T09:18:44Z (GMT). No. of bitstreams: 1
ntu-101-R99643008-1.pdf: 2105082 bytes, checksum: 7fde7c179d04561ac99d7de92d178e65 (MD5)
Previous issue date: 2012
en
dc.description.tableofcontents目錄------------------------i
表次--------------------------------iii
圖次-------------------------------iv
中文摘要---------------------------v
Abstract--------------------------vii
第一章、序言----------------------1
第二章、文獻探討-----------------2
第一節、歷史背景--------------2
第二節、犬瘟熱病毒之介紹-----2
2.2.1 分類及特性----------2
2.2.2 流行病學---------------4
2.2.3 傳播途徑與排毒模式----4
2.2.4 致病機制--------------5
第三節、感染犬隻病毒清除之免疫反應----------------7
第四節、臨床特徵-------------8
第五節、診斷-------------------9
2.5.1 血液學檢查------------9
2.5.2 腦脊髓液檢查--------9
2.5.3 快速診斷試劑--------9
2.5.4 免疫學診斷技術-----10
2.5.5 病毒分離-------------10
2.5.6 分子生物學技術-----10
第六節、治療與預防--------11
第三章、材料與方法-------------13
第一節、動物來源------------13
第二節、血檢值與影像學診斷------------13
第三節、巢式聚合酶連鎖反應(Nested polymerase chain
reaction,nPCR)寡核苷酸引子之選擇-----------14
第四節、以RT-nPCR偵測CDV核酸----14
3.4.1、病毒RNA的萃取-----14
3.4.2、反轉錄反應(Reverse transcription, RT) ---15
3.4.3、聚合酶連鎖反應(Polymerase chain reaction) ---15
3.4.4、巢式聚合酶連鎖反應(Nested polymerase chain
reaction,nPCR)------15
3.4.5、以電泳分析聚合酶連鎖反應---------16
3.4.6、陽性病例之判讀----16
第五節、高免血漿之製作------16
3.5.1、犬源血漿來源------16
3.5.2、中和抗體力價試驗---16
3.5.2.1、細胞及病毒---------16
3.5.2.2、血清中和試驗 (Serum neutralization test) --17
第六節、組織病理學診斷與免疫化學染(Immunohistochemistry,
IHC)------17
第七節、統計分析-------------17
第四章、結果----------------------18
第一節、動物基本資料--------18
第二節、Group 1 RT-nPCR結果與臨床症狀之關聯性分析-----18
第三節、高免血漿之治療成效------------18
第四節、四十隻犬瘟患犬之血檢值與影像學診斷分析---------19
4.4.1 出現神經症狀犬瘟患犬之血檢值與影像學診斷分析---19
4.4.2 從未出現神經症狀犬瘟患犬之血檢值與影像學診斷分析19
第五節、中和抗體力價之影響-----20
第六節、Group1出現神經症狀患犬之RT-nPCR結果與組織病理學診
斷分析-20
4.6.1 Group1中出現神經症狀患犬存活組與死亡組之分析--20
4.6.2 Group1中出現神經症狀死亡患犬之組織病理學與免疫化學
染色(IHC)診斷結果------------20
第七節 類固醇給予時間之影響--------21
第五章、討論---------------------23
參考文獻----------------------30
附表----------------------------43
附圖----------------------59
附錄一-----62
dc.language.isozh-TW
dc.title高免血漿應用於犬瘟熱患犬治療效果之評估zh_TW
dc.titleThe Therapeutic Efficacy of Hyperimmune Plasma in Canine Distemper Dogsen
dc.typeThesis
dc.date.schoolyear101-1
dc.description.degree碩士
dc.contributor.coadvisor闕玲玲
dc.contributor.oralexamcommittee王金和,梁鍾鼎
dc.subject.keyword犬瘟熱,神經症狀,高免血漿,被動免疫,zh_TW
dc.subject.keywordcanine distemper,neurological signs,hyperimmune plasma,passive immunity,en
dc.relation.page62
dc.rights.note同意授權(全球公開)
dc.date.accepted2012-09-26
dc.contributor.author-college獸醫專業學院zh_TW
dc.contributor.author-dept臨床動物醫學研究所zh_TW
Appears in Collections:臨床動物醫學研究所

Files in This Item:
File SizeFormat 
ntu-101-1.pdf2.06 MBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved